United Capital Financial Advisers LLC Grows Holdings in CVS Health Corp (CVS)

United Capital Financial Advisers LLC raised its position in CVS Health Corp (NYSE:CVS) by 57.7% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 357,100 shares of the pharmacy operator’s stock after acquiring an additional 130,586 shares during the period. United Capital Financial Advisers LLC’s holdings in CVS Health were worth $22,394,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Wasatch Advisors Inc. raised its stake in shares of CVS Health by 78.5% during the 4th quarter. Wasatch Advisors Inc. now owns 152,422 shares of the pharmacy operator’s stock worth $11,051,000 after purchasing an additional 67,022 shares in the last quarter. E&G Advisors LP raised its stake in shares of CVS Health by 30.9% during the 4th quarter. E&G Advisors LP now owns 6,771 shares of the pharmacy operator’s stock worth $491,000 after purchasing an additional 1,600 shares in the last quarter. National Pension Service raised its stake in shares of CVS Health by 1.5% during the 4th quarter. National Pension Service now owns 850,361 shares of the pharmacy operator’s stock worth $61,651,000 after purchasing an additional 12,886 shares in the last quarter. Thompson Rubinstein Investment Management Inc. OR raised its stake in shares of CVS Health by 5.7% during the 4th quarter. Thompson Rubinstein Investment Management Inc. OR now owns 42,726 shares of the pharmacy operator’s stock worth $3,098,000 after purchasing an additional 2,300 shares in the last quarter. Finally, Creative Planning raised its stake in shares of CVS Health by 6.6% during the 4th quarter. Creative Planning now owns 96,576 shares of the pharmacy operator’s stock worth $7,002,000 after purchasing an additional 6,009 shares in the last quarter. Hedge funds and other institutional investors own 83.16% of the company’s stock.

CVS has been the topic of a number of research analyst reports. Mizuho set a $95.00 price target on CVS Health and gave the company a “buy” rating in a research note on Wednesday, June 13th. Bank of America dropped their price target on CVS Health from $91.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, April 11th. Leerink Swann set a $85.00 price target on CVS Health and gave the company a “buy” rating in a research note on Tuesday, April 10th. Loop Capital set a $68.00 price target on CVS Health and gave the company a “hold” rating in a research note on Monday, May 7th. Finally, ValuEngine cut CVS Health from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $86.27.

In related news, Director C David Brown II bought 10,000 shares of CVS Health stock in a transaction dated Friday, May 4th. The shares were bought at an average cost of $61.99 per share, with a total value of $619,900.00. Following the acquisition, the director now owns 101,252 shares in the company, valued at approximately $6,276,611.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.53% of the company’s stock.

Shares of NYSE CVS opened at $72.18 on Friday. The company has a current ratio of 2.37, a quick ratio of 1.88 and a debt-to-equity ratio of 1.59. CVS Health Corp has a one year low of $60.14 and a one year high of $84.00. The firm has a market capitalization of $72.26 billion, a price-to-earnings ratio of 12.23, a PEG ratio of 0.99 and a beta of 1.00.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, May 2nd. The pharmacy operator reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.09. CVS Health had a return on equity of 17.45% and a net margin of 3.59%. The firm had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.77 billion. During the same period in the prior year, the firm posted $1.17 EPS. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. equities analysts forecast that CVS Health Corp will post 6.98 earnings per share for the current fiscal year.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply